Beigene Chart News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Beigene Chart. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Beigene Chart Today - Breaking & Trending Today

BeiGene's Biologics License Application for TEVIMBRA (tislelizumab) for First-Line Gastric or Gastroesophageal Junction Cancers Accepted by FDA Seite 1

Published: February 27, 2024

27.02.2024 - BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has accepted a Biologics License Application (BLA) for TEVIMBRA (tislelizumab), in combination with ... Seite 1

Source: wallstreet-online.de

BeiGene Presentations at ESMO 2023 Demonstrate Robust Clinical Strategy for Tislelizumab as Monotherapy and in Combination with Pipeline Assets

Published: October 16, 2023

16.10.2023 - BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, today announced the presentation of promising new data showcasing BeiGene’s robust, science-driven solid tumor portfolio of commercialized and pipeline medicines ... Seite 1

Source: wallstreet-online.de

BeiGene Strengthens Global Portfolio and Regains Full Rights from Novartis for Anti-PD-1 Antibody TEVIMBRA (tislelizumab)

Published: September 19, 2023

19.09.2023 - BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, today announced that it has entered into an agreement with Novartis to regain worldwide rights to develop, manufacture, and commercialize TEVIMBRA ... Seite 1

Source: wallstreet-online.de